Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors.
暂无分享,去创建一个
D. Collins | A. Padhani | D. Koh | G. Rustin | M. Leach | J. d’Arcy | P. Nathan | I. Judson | J. D. de Bono | G. Attard | N. Taylor | S. Pacey | P. Stopfer | M. Stefanic | C. Lee | S. Bell | A. Tang | G. Temple